Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Philadelphia, Pennsylvania 19124


Purpose:

To compare bromfenac 0.09%, diclofenac sodium 0.1%, and ketorolac tromethamine 0.5% ophthalmic solutions for the treatment of acute pseudophakic CME after cataract surgery.


Criteria:

Inclusion Criteria: - Patients must be diagnosed with acute pseudophakic CME within 12 months of cataract surgery - Males and females 18 years and older - Able to provide written informed consent Exclusion Criteria: - Complicated cataract surgery, particularly posterior capsule rupture and vitreous loss - Pre-Existing macular pathology, including macular edema, macular scar, macular hole, or macular pucker - History of Uveitis - Ipsilateral intraocular surgery prior to cataract surgery - CME greater than one year duration


NCT ID:

NCT00595543


Primary Contact:

Principal Investigator
David Rho, MD
Soll Eye Associates


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19124
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.